首页> 外文会议>International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) >A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease
【24h】

A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease

机译:认知干预对老年人和阿尔茨海默氏病患者疗效的随机,安慰剂对照研究

获取原文
获取原文并翻译 | 示例

摘要

Research on non-pharmacological therapies (cognitive rehabilitation) in old age has been very limited, and most has not considered the effect of intervention of this type over extended periods of time. The aim of Donostia Longitudinal Study was to investigate a new cognitive therapy in a randomized, placebo-controlled group of elderly people over 65 years of age without cognitive deterioration or expressed AAMI (Age Associated Memory Impairment) and patients with a Alzheimer's Disease (AD). The efficacy of this therapy was evaluated by means of post-hoc analysis of 390 people using biomedical, neuropsy-chological, affective, and personality assessments. In the GDS 1-2 grouping, scores for learning potential and different types of memory for the treatment group improved significantly relative to the untreated controls. While, subjects with a GDS 3-4 showed significantly better performance on Neuropsychiatric inventory (NPI) scores in all domains (anxiety, depression, apathy, sleep disturbances). Finally subjects with a GDS 5-6, showed a maintenance of cognitive capacities. In the GDS 1-2 grouping, the most significant result found is that learning potential of trained people enhances within two years of intervention, this involves a successful ageing sign and plays a preventive role in dementia development. On the other hand, in the GDS 3-4 and GDS 5-6 grouping, the behavioral disturbances diminished within this intervention, so this type of training program could be beneficial on them.
机译:老年非药物疗法(认知康复)的研究非常有限,并且大多数人还没有考虑过这种类型的干预措施的效果。 Donostia纵向研究的目的是研究一种新的认知疗法,用于随机,安慰剂对照的65岁以上,无认知能力减退或表达AAMI(年龄相关记忆障碍)的老年人以及患有阿尔茨海默氏病(AD)的患者。通过生物医学,神经解剖学,情感和人格评估对390人进行事后分析,评估了该疗法的疗效。在GDS 1-2分组中,与未治疗的对照组相比,治疗组的学习潜能和不同类型的记忆力得分明显提高。同时,GDS 3-4的受试者在所有领域(焦虑,抑郁,冷漠,睡眠障碍)的神经精神病学调查表(NPI)得分均表现出明显更好的表现。最终,GDS 5-6的受试者表现出认知能力的维持。在GDS 1-2分组中,发现的最重要结果是,受过培训的人员的学习潜力在干预的两年内会增强,这涉及成功的衰老迹象,并在痴呆症发展中起到预防作用。另一方面,在GDS 3-4和GDS 5-6分组中,行为干扰在此干预措施内有所减少,因此这种类型的培训计划可能会对他们有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号